Ping Gong

发表

Based on 2-(difluoromethyl)-1-[4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl]-1H-benzimidazole (ZSTK474), design, synthesis and biological evaluation of novel PI3Kα selective inhibitors.

Yu Wang, Yanfang Zhao, Yajing Liu, 2022, Bioorganic chemistry.

Design, synthesis, and biological evaluation of novel dihydropteridone derivatives possessing oxadiazoles moiety as potent inhibitors of PLK1.

Xinzi He, Yanfang Zhao, Yajing Liu, 2023, European journal of medicinal chemistry.

Improved protocol for synthesizing (3Z,6Z)-3-benzylidene-6-[(5-tert-butyl-1H-imidazol-4-yl)methylidene]piperazine-2,5-dione (plinabulin)

Xinyue Yu, Huanhuan Chen, Mingze Qin, 2023, Chemical Papers.

MZH29 is a novel potent inhibitor that overcomes drug resistance FLT3 mutations in acute myeloid leukemia

Benhong Xu, W. Ge, P. Gong, 2017, Leukemia.

A Novel Selective Method for the Synthesis of α‐Bromoacetophenone and α,α‐ Dibromoacetophenone Using NaBr/K 2 S 2 O 8

Huanhuan Chen, Mingze Qin, Ping Gong, 2022, ChemistrySelect.

Design and Synthesis of 1,3,5-Triazines or Pyrimidines Containing Dithiocarbamate Moiety as PI3Kα Selective Inhibitors.

Yanfang Zhao, Yajing Liu, Siyu Fu, 2023, ACS medicinal chemistry letters.

Discovery andw biological evaluation of novel 6,7-disubstituted-4-(2-fluorophenoxy)quinoline derivatives possessing 1,2,3-triazole-4-carboxamide moiety as c-Met kinase inhibitors.

Rui-Juan Li, Yanfang Zhao, Huimin Liao, 2014, Bioorganic & medicinal chemistry.

Multigram‑scale synthesis of BTK inhibitor BIIB068

Xinyue Yu, Sixuan Wang, M. Guo, 2023, Chemical Papers.

Bioactivities and the structural modification of Parthenolide: a review

Ping Gong, Jie Wu, Xiaoqian Wang, 2023, Medicinal Chemistry Research.